Home » Healthcare » US Medical and Diagnostic Laboratory Service Market

US Medical and Diagnostic Laboratory Service Market By Clinical Laboratory Services (Pathology Services, Clinical Chemistry, Hematology, Microbiology); By Diagnostic Imaging Services (Radiology Services, Ultrasound Services); By Genetic Testing and Molecular Diagnostics, Genetic Testing, Molecular Diagnostics); By Blood Banking and Transfusion Services (Blood Typing and Crossmatching, Blood Donation Services); By Point-of-Care Testing (Rapid Tests, Home Testing Kits); By Drug Testing Services (Workplace Drug Testing, Forensic Drug Testing); By Anatomic Pathology Services (Surgical Pathology, Cytopathology); By Wellness and Preventive Health Testing (Health Screenings, Preventive Testing Packages); By Home Healthcare Testing Services (Remote Monitoring, Home-Based Diagnostics); By Cardiac Diagnostic Services (Cardiac Imaging, Electrocardiography (ECG or EKG)); By Infectious Disease Testing (Virology and Serology, Microbial Culture and Sensitivity); By Women’s Health Testing (Prenatal Testing, Breast Cancer Screening); By Urinalysis and Fluid Analysis (Urinalysis, Body Fluid Analysis); By Telehealth and Remote Diagnostics (Telehealth Services, Remote Diagnostics); By Health Information Management and Reporting (Electronic Health Records (EHR), Health Information Exchange (HIE)) – Growth, Future Prospects & Competitive Analysis, 2022 – 2030

Summary
Table Of Content

Market Insights

The US demand for medical and diagnostic laboratory services was valued at USD 72514.8 million in 2022 and is expected to reach USD 149878.59 million in 2030, growing at a CAGR of 9.50% between 2023 and 2030.
Pathology services are the leading segment of clinical laboratory services. Clinical chemistry, on the other hand, is expected to grow at a strong CAGR.
The leading diagnostic imaging services segment is radiology services.
The CAGR for genetic testing is expected to be the highest during the projection period.
During the forecast time frame, the blood typing and crossmatching category will likely have the highest CAGR.
The rapid tests segment is estimated to have the greatest CAGR during the forecast period.
The workplace drug testing segment will likely have the highest CAGR during the prediction period.
The most popular category for anatomic pathology services is surgical pathology.
The health screenings segment’s CAGR will be the top during the projected period.
The best method for providing home healthcare testing services is remote monitoring.
During the forecast period, cardiac imaging is the segment with the highest estimated CAGR.
During the forecast period, the virology and serology sector will probably have the greatest CAGR.
Significant CAGR growth is anticipated for prenatal testing.
In clinical trials and research studies, urinalysis is used to collect data on various health-related indicators and evaluate the efficacy of therapies.
For telehealth services, a substantial CAGR growth is predicted.
Electronic health record systems make it possible for patient data to be shared easily between various healthcare facilities, including clinics, hospitals, and labs. Making decisions in a fast and correct manner depends on this interoperability.

Due to the prevalence of chronic diseases, aging populations, and improvements in diagnostic technologies, the market for medical and diagnostic laboratory services has expanded in the United States.
The trends generating potential for the US market are the shift towards personalized medicine, telehealth and remote monitoring, and government initiatives and regulations.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Executive Summary

Market Definition

The healthcare industry’s area that includes a broad range of services associated with laboratory analysis, diagnostics, and medical testing is known as the U.S. medical and diagnostic laboratory services market. In order to help healthcare professionals diagnose, track, and treat a wide range of medical disorders, this market is essential.

Market Overview

The US medical and diagnostic laboratory service industry has been growing consistently in recent years, and it is expected to grow at a CAGR of 9.50% between 2023 and 2030. The market was estimated to be worth USD 72514.8 million in 2022, and it is anticipated to be worth USD 149878.59 million in 2030.

Leading companies in the U.S. industry are putting more of an emphasis on building automated clinical diagnostic labs and healthcare systems. Medical laboratory services now offer a wide range of automated processes and sophisticated equipment. In September 2022, Scitara Corporation declared a collaboration with Agilent Technologies, Inc. to include its Scientific Integration Platform (SIP) with Agilent’s Software and Informatics Division product line, encompassing lab workflow management solutions and chromatography software.

Segmentation by Clinical Laboratory Services

Pathology services are the market leader in clinical laboratory services. Medical experts, general physicians, and their patients in hospitals and the community can receive diagnostic and consultation services from pathology services.
The clinical chemistry category will exhibit a sizable CAGR during the projected period. This study area focuses on quantifying the concentrations of particular compounds, such as glucose, cholesterol, electrolytes, enzymes, and hormones, in bodily fluids using chemical and biochemical methods. Assessing organ function and diagnosing and tracking illnesses are the objectives.

Segmentation by Diagnostic Imaging Services

The main diagnostic imaging services category is radiology services. The main method used to manage all diseases is radiology. It also includes a range of methods and instruments for finding, examining, and treating. Furthermore, it is how the physician obtains comprehensive knowledge about structural alterations associated with the condition.
The ultrasound services category will likely register a significant CAGR during forecasting. With ultrasound imaging, sound waves produce images of inside structures in a safe, non-invasive diagnostic procedure. It is especially appealing for use in obstetrics, cardiology, and abdominal imaging, among other medical applications, because of its features.

Segmentation by Genetic Testing and Molecular Diagnostics

The genetic testing category is anticipated to experience the highest CAGR during the projection period. Genetic testing scans your DNA for alterations, often known as mutations or variations. Genetic testing can affect the medical care that you or a family member receives and is helpful in many areas of medicine.
Molecular diagnostics also contribute to the demand for US medical and diagnostic laboratory services.

Segmentation by Blood Banking and Transfusion Services

The blood typing and crossmatching category will likely have the highest CAGR during the projection period. The technique of identifying a sample of blood’s type of blood and rH factor is known as blood typing. Before a blood transfusion, crossmatching entails locating the most suitable donor for the patient. Minor blood groups are assessed in addition to the blood type and rH.
Blood donation services also increase the demand for US medical and diagnostic laboratory services.

Segmentation by Point-of-Care Testing

Rapid tests will be expected to have the foremost CAGR during the prediction period. Rapid tests are simple to perform and yield findings quickly—typically in 20 minutes or less. They are often referred to as rapid diagnostic tests or RDTs.
Home testing kits also contribute to the demand for US medical and diagnostic laboratory services.

Segmentation by Drug Testing Services

Throughout the forecast duration, the category for workplace drug testing is anticipated to have the greatest CAGR. Employee drug testing is required by specific industries and by federal and state regulations. This is more typical in industries like transportation, aviation, and healthcare, where people’s safety is a top priority. Drug tests at work are demanded by compliance with these regulations.
Forensic drug testing also influences the need for US medical and diagnostic laboratory services.

Segmentation by Anatomic Pathology Services

The highest CAGR is anticipated for surgical pathology throughout estimation. The investigation of tissues taken from living patients during surgery to aid in disease diagnosis and therapy planning is known as surgical pathology. Surgical pathologists frequently offer consultations in various medical subspecialties and organ systems.
The demand for US medical and diagnostic laboratory services is also influenced by cytopathology.

Segmentation by Wellness and Preventive Health Testing

Over the estimation period, health screenings are expected to have the greatest CAGR. A screening test is performed to identify possible illnesses or health problems when a person has no signs of a condition. Preventing disease or detecting it early enough to receive the best possible treatment are the main objectives of early detection, lifestyle modifications, and surveillance.
Preventive testing packages also contribute to the demand for US medical and diagnostic laboratory services.

Segmentation by Home Healthcare Testing Services

Over the estimated timeframe, remote monitoring is anticipated to experience the highest CAGR. By connecting it to a network through remote monitoring, laboratory equipment can be continuously monitored for performance and status. There is less need for manual intervention due to this connectivity, which allows automated data collection.
Home-based diagnostics also contribute to the demand for US medical and diagnostic laboratory services.

Segmentation by Cardiac Diagnostic Services

Throughout the forecast period, the category of cardiac imaging is expected to grow at the most rapid rate. Several procedures that use images of your heart and associated structures are called cardiac imaging tests. To identify and treat cardiac problems, medical professionals use the tests. Nuclear cardiac stress testing, heart magnetic resonance imaging, and chest X-rays are a few cardiac imaging techniques.
Electrocardiography (ECG or EKG) also contributes to the demand for US medical and diagnostic laboratory services.

Segmentation by Infectious Disease Testing

During the estimation stage, virology and serology are expected to have the greatest CAGR. A variety of viruses and other organisms, such as HIV, hepatitis B and C, and syphilis, can be detected in the blood via antibodies and antigens that are found in serum, which is tested for by the Virology and Microbial Serology department.
Microbial culture and sensitivity also contribute to the demand for US medical and diagnostic laboratory services.

Segmentation by Women’s Health Testing

The category for prenatal testing is predicted to have the highest CAGR for the course of the prediction. One method for identifying certain birth abnormalities at different stages before delivery is prenatal testing.
Breast cancer screening also influences US medical and diagnostic laboratory service demand.

Segmentation by Urinalysis and Fluid Analysis

During the projected period, the category of urinalysis is expected to exhibit the highest compound annual growth rate. Urine testing is known as a urinalysis. It is frequently performed to screen for diabetes, renal issues, or urinary tract infections.
Body fluid analysis also contributes to the demand for US medical and diagnostic laboratory services.

Segmentation by Telehealth and Remote Diagnostics

Telehealth services are more popular. The use of communications technology to deliver medical care remotely is known as telehealth. The convergence of medical technologies, computer science, informatics, and communications breakthroughs has made telehealth an invaluable resource.
Remote diagnostics also drive the need for US medical and diagnostic laboratory services.

Segmentation by Health Information Management and Reporting

Electronic health records (EHR) are expected to surge the fastest over the projected period. A population’s and patients’ systematic electronic health record, or EHR, is a digitally stored, systematized health data collection.
Health information exchange (HIE) also contributes to the demand for US medical and diagnostic laboratory services.

Biomarkers are used in US medical and diagnostic labs to quantify health metrics related to personal well-being. Biomarkers are a useful tool for measuring an individual’s health and well-being to determine the causes of sleep disturbances and stress-related symptoms. Immunological system alterations associated with physical and mental health issues can be detected by biomarkers such as secretory IgA, testosterone, and cortisol. Physicians can use this to determine the underlying causes of certain diseases. This is a high-end service aimed mostly at affluent people and corporate executives.

Key Highlights of the Report

The US medical and diagnostic laboratory service market is segmented by clinical laboratory services, diagnostic imaging services, genetic testing and molecular diagnostics, blood banking, and transfusion services, point-of-care testing, drug testing services, anatomic pathology services, wellness and preventive health testing, home healthcare testing services, cardiac diagnostic services, infectious disease testing, women’s health testing, urinalysis and fluid analysis, telehealth and remote diagnostics, and health information management and reporting. Regarding clinical laboratory services, pathology services are the market spearhead. Radiology services are the top diagnostic imaging services segment. The genetic testing category is expected to grow at the highest CAGR during the forecast period. The workplace drug testing category will experience the highest CAGR during the forecast period.

The major players in the US market for medical and diagnostic laboratory services are concentrating on creating cutting-edge products like laboratory benefit management systems to obtain a competitive advantage. A medical service that maximizes and simplifies the use of laboratory tests is called a laboratory benefit management solution. For example, the US healthcare corporation Optum Inc. introduced a laboratory benefit management system in June 2022.

The goal of the solution is to assist health plans in minimizing needless lab testing while guaranteeing that their members obtain appropriate, superior testing. Health plans can more effectively control lab test use and costs by using a solution which harmonizes testing with clinical evidence. Health plans have the potential to save anywhere from $12 to $36 per member year, or over $3 billion yearly.

Which Key Factors Are Driving The US Medical and Diagnostic Laboratory Service Market?

The expansion of point-of-care testing, advancements in customized medicine, and rising healthcare costs have all contributed to the growth of the medical and diagnostic laboratory services market in the United States.

What Are The Key Challenges In The US Medical and Diagnostic Laboratory Services Market?

Telemedicine adoption is limited, fee-for-service models are overused, and internal laboratory competition is prominent. The US market for services related to medical and diagnostic laboratories has these major challenges.

What Market Opportunities Exist For US Medical and Diagnostic Laboratory Services?

Greater availability of health insurance, integration with electronic health data, and a focus on preventive healthcare. Due to these aspects, the US market for medical and diagnostic laboratory services has significant opportunities.

Market Drivers

Several factors influence the market for US medical and diagnostic laboratory services. The main factors influencing the market for US medical and diagnostic laboratory services are as follows:

An Increasing Number of Chronic Illnesses

The need for medical laboratory services is expected to rise due to the increasing incidence of infectious and chronic disorders such as breast cancer, sickle cell disease, Down syndrome, and cystic fibrosis. In addition, the rise in the prevalence of chronic illnesses has resulted in a rise in hospital admissions and clinical laboratory tests recommended by healthcare professionals. For example, the National Centre for Biotechnology Information (NCBI) reported in April 2023 that 129,624 genetic tests—including upgraded versions of the previously available ones—were made available in the United States. The US Medical and Diagnostic Laboratory Service Market is growing due to the significant demand for early diagnosis and the growing need for medical laboratory services.

Market Restraints

Several challenges could prevent the expansion of the US market for medical and diagnostic laboratory services. Among them are the following:

Cost Pressure for Services Associated with Medical Lab Testing

Several reasons may hinder the growing need for medical laboratory tests in the upcoming years. One of the main elements predicted to impede the market’s expansion is the mounting pressure on prices. The diagnostic segment’s heavy discounting and inappropriate price practices are the primary causes of the extreme pricing pressure the diagnostic industry is experiencing. For example, in September 2022, four out of ten Americans reported that they had postponed or cancelled a medical procedure in the previous year, and that 17.0% had not filled a prescription because of the high cost of tests in the area. Therefore, it is projected that during the projection period, the growing pressure on prices for medical laboratory services will restrain market expansion. In the United States, an estimated 28.7 million people (28.5% of the population) have been diagnosed with diabetes as of 2022, while an additional 8.5 million go undiagnosed. These figures are from the Centers for Disease Control and Prevention.

Opportunities

The US market for medical and diagnostic laboratory services presents significant potential opportunities. The following is an example of these:

Escalating Need for Customised Treatment

The U.S. Medical and Diagnostic Laboratory Services Market is rising, and one major factor contributing to this growth is the growing desire for customized healthcare. Genomics testing and molecular diagnostics are widely used in personalized medicine to pinpoint particular genetic variants linked to various illnesses. Analysis of genetic material and biomarkers necessitates sophisticated laboratory services. Knowing how a person’s genetic composition affects how they react to medications is part of personalized medicine. Based on a person’s genetic profile, pharmacogenomic testing assists in identifying the safest and most effective pharmaceuticals for them. Analyzing a tumor’s genetic composition to inform treatment choices is known as personalized medicine in cancer. One way to do this would be to find particular genetic alterations that can be the target of precision medicine.

Competitive Landscape

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Players

The US medical and diagnostic laboratory services market is very competitive, with many powerful players. Some of the leading market participants and their corresponding market shares are listed below:

Mayo Clinic Laboratories
Genomic Health, Inc.
Myriad Genetics, Inc.
Others

These companies prioritize mergers and acquisitions, expanding their distribution network, and developing new products to remain competitive.

The leading competitors in the US market for medical and diagnostic laboratory services are constantly looking for ways to get an advantage by releasing new items and advancements.

In March 2023, Myriad Genetics Inc. and Illumina Inc. extended their strategic alliance to increase the accessibility and availability of Homologous Recombination Deficiency (HRD) testing for cancer in the United States.

In July 2022, The U.S. Centers for Disease Control and Prevention (CDC) orthopoxvirus test was used by Laboratory Corporation of America to start testing for monkeypox. First, to introduce a more automated assay and provide a Polymerase Chain Reaction (PCR) test approved by the CDC, LabCorp is a pioneer in national laboratories.

Summary of Key Findings

The US medical and diagnostic laboratory services market is expanding due to healthcare digitization.
The market is segmented by clinical laboratory services, diagnostic imaging services, genetic testing and molecular diagnostics, blood banking, and transfusion services, point-of-care testing, drug testing services, anatomic pathology services, wellness and preventive health testing, home healthcare testing services, cardiac diagnostic services, infectious disease testing, women’s health testing, urinalysis and fluid analysis, telehealth and remote diagnostics, and health information management and reporting.
Pathology services are the most preferred clinical laboratory services.
Radiology services are the most common in terms of diagnostic imaging services.
Regarding CAGR, rapid tests are expected to grow fastest during the forecast period.
The category for surgical pathology will likely see the highest CAGR during the anticipated time frame.
The US medical and diagnostic laboratory service market is highly competitive, with key players including Mayo Clinic Laboratories, Genomic Health, Inc., Myriad Genetics, Inc., and others.

Future Outlook

Optimistic viewpoint for the medical and diagnostic laboratory service industry with noteworthy growth potential in the US.
Increases in well-being and lifestyle testing spur the growth of the medical and diagnostic laboratory service market in the United States.
The complexity of diagnostic testing limits the growth of the US medical and diagnostic laboratory services market.
Foremost companies must concentrate on product innovation, expanding their market reach, and maintaining competitive pricing to stay ahead.

How CXOs Can Benefit from the Credence Research US Medical and Diagnostic Laboratory Service Market Report

The Credence Research US Medical and Diagnostic Laboratory Service Market Report provides CXOs with a comprehensive overview of the market, including:

Market size and growth forecast: The report provides detailed estimates of the US medical and diagnostic laboratory service market size, segmented by clinical laboratory services, diagnostic imaging services, genetic testing and molecular diagnostics, blood banking and transfusion services, point-of-care testing, drug testing services, anatomic pathology services, wellness and preventive health testing, home healthcare testing services, cardiac diagnostic services, infectious disease testing, women’s health testing, urinalysis and fluid analysis, telehealth and remote diagnostics, and health information management and reporting. It also includes forecasts for the market through 2032 based on key trends and drivers.
Market segmentation: The report segments the US Medical and Diagnostic Laboratory Service market by clinical laboratory services, diagnostic imaging services, genetic testing and molecular diagnostics, blood banking and transfusion services, point-of-care testing, drug testing services, anatomic pathology services, wellness and preventive health testing, home healthcare testing services, cardiac diagnostic services, infectious disease testing, women’s health testing, urinalysis and fluid analysis, telehealth and remote diagnostics, and health information management and reporting. This segmentation provides CXOs with a granular understanding of the market and the opportunities in each segment.
Competitive landscape: The report profiles the key players in the US medical and diagnostic laboratory service market and provides insights into their strategies, product offerings, and financial performance. This information can help CXOs to identify and assess their competition.
Key trends and drivers: The report identifies and analyzes the key trends and drivers shaping the US medical and diagnostic laboratory service market. This information can help CXOs to make informed decisions about their investments and strategies.

CXOs can use the insights from the Credence Research US Medical and Diagnostic Laboratory Service Market Report to:

Identify growth opportunities: The report can help CXOs identify new growth opportunities in the US medical and diagnostic laboratory service market. For example, the report identifies the rising demand for medical and diagnostic laboratory services from hospitals and healthcare facilities as a key opportunity.
Make informed investment decisions: The report can help CXOs make informed investment decisions about medical and diagnostic laboratory services. For example, the report provides insights into the key factors to consider when evaluating medical and diagnostic laboratory service providers and selecting solutions.
Develop competitive strategies: The report can help CXOs develop competitive strategies for their medical and diagnostic laboratory service businesses. For example, the report identifies medical and diagnostic laboratory service providers’ key strategies to differentiate themselves from competitors.
Track market developments: The report can help CXOs track and stay ahead of the curve. For example, the report provides insights into the latest trends and innovations in the US medical and diagnostic laboratory service market.

Overall, the Credence Research US Medical and Diagnostic Laboratory Service Market Report is a valuable resource for CXOs looking to understand the market better and identify growth opportunities.

Segmentation

By Clinical Laboratory Services
- Pathology Services
- Clinical Chemistry
- Hematology
- Microbiology
By Diagnostic Imaging Services
- Radiology Services
- Ultrasound Services
By Genetic Testing and Molecular Diagnostics
- Genetic Testing
- Molecular Diagnostics
By Blood Banking and Transfusion Services
- Blood Typing and Crossmatching
- Blood Donation Services
By Point-of-Care Testing
- Rapid Tests
- Home Testing Kits
By Drug Testing Services
- Workplace Drug Testing
- Forensic Drug Testing
By Anatomic Pathology Services
- Surgical Pathology
- Cytopathology
By Wellness and Preventive Health Testing
- Health Screenings
- Preventive Testing Packages
By Home Healthcare Testing Services
- Remote Monitoring
- Home-Based Diagnostics
By Cardiac Diagnostic Services
- Cardiac Imaging
- Electrocardiography (ECG or EKG)
By Infectious Disease Testing
- Virology and Serology
- Microbial Culture and Sensitivity
By Women’s Health Testing
- Prenatal Testing
- Breast Cancer Screening
By Urinalysis and Fluid Analysis
- Urinalysis
- Body Fluid Analysis
By Telehealth and Remote Diagnostics
- Telehealth Services
- Remote Diagnostics
By Health Information Management and Reporting
- Electronic Health Records (EHR)
- Health Information Exchange (HIE)

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: US Medical and Diagnostic Laboratory Service Market
2.1.1. US Medical and Diagnostic Laboratory Service Market, By Clinical Laboratory Services
2.1.2. US Medical and Diagnostic Laboratory Service Market, By Diagnostic Imaging Services
2.1.3. US Medical and Diagnostic Laboratory Service Market, By Genetic Testing and Molecular Diagnostics
2.1.4. US Medical and Diagnostic Laboratory Service Market, By Blood Banking and Transfusion Services
2.1.5. US Medical and Diagnostic Laboratory Service Market, By Point-of-Care Testing
2.1.6. US Medical and Diagnostic Laboratory Service Market, By Drug Testing Services
2.1.7. US Medical and Diagnostic Laboratory Service Market, By Anatomic Pathology Services
2.1.8. US Medical and Diagnostic Laboratory Service Market, By Wellness and Preventive Health Testing
2.1.9. US Medical and Diagnostic Laboratory Service Market, By Home Healthcare Testing Services
2.1.10. US Medical and Diagnostic Laboratory Service Market, By Cardiac Diagnostic Services
2.1.11. US Medical and Diagnostic Laboratory Service Market, By Infectious Disease Testing
2.1.12. US Medical and Diagnostic Laboratory Service Market, By Women’s Health Testing
2.1.13. US Medical and Diagnostic Laboratory Service Market, By Urinalysis and Fluid Analysis
2.1.14. US Medical and Diagnostic Laboratory Service Market, By Telehealth and Remote Diagnostics
2.1.15. US Medical and Diagnostic Laboratory Service Market, By Health Information Management and Reporting
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. US Medical and Diagnostic Laboratory Service Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Medical and Diagnostic Laboratory Service Market Drivers
3.2.2. Medical and Diagnostic Laboratory Service Market Restraints
3.2.3. Medical and Diagnostic Laboratory Service Market Opportunities
3.2.4. Major Medical and Diagnostic Laboratory Service Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Clinical Laboratory Services
3.5.2. Diagnostic Imaging Services
3.5.3. Genetic Testing and Molecular Diagnostics
3.5.4. Blood Banking and Transfusion Services
3.5.5. Point-of-Care Testing
3.5.6. Drug Testing Services
3.5.7. Anatomic Pathology Services
3.5.8. Wellness and Preventive Health Testing
3.5.9. Home Healthcare Testing Services
3.5.10. Cardiac Diagnostic Services
3.5.11. Infectious Disease Testing
3.5.12. Women’s Health Testing
3.5.13. Urinalysis and Fluid Analysis
3.5.14. Telehealth and Remote Diagnostics
3.5.15. Health Information Management and Reporting
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. US Medical and Diagnostic Laboratory Service Market: Company Market Share, Value 2022
4.1.2. US Medical and Diagnostic Laboratory Service Market: Top 6 Company Market Share, Value 2022
4.1.3. US Medical and Diagnostic Laboratory Service Market: Top 3 Company Market Share, Value 2022
4.2. US Medical and Diagnostic Laboratory Service Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the US Medical and Diagnostic Laboratory Service Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the US market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID 19 and Russia – Ukraine War on US Medical and Diagnostic Laboratory Service Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Impact Analysis
7.2.5.1. US
8. US Medical and Diagnostic Laboratory Service Market, By Clinical Laboratory Services
8.1. US Medical and Diagnostic Laboratory Service Market Overview, by Clinical Laboratory Services
8.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Clinical Laboratory Services, 2022 Vs 2030 (in %)
8.2. Pathology Services
8.2.1. US Medical and Diagnostic Laboratory Service Market, By Pathology Services, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for Pathology Services
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Clinical Chemistry
8.3.1. US Medical and Diagnostic Laboratory Service Market, By Clinical Chemistry, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for Clinical Chemistry
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Hematology
8.4.1. US Medical and Diagnostic Laboratory Service Market, By Hematology, 2017-2030 (US$ Mn)
8.4.2. Market Dynamics for Hematology
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Microbiology
8.5.1. US Medical and Diagnostic Laboratory Service Market, By Microbiology, 2017-2030 (US$ Mn)
8.5.2. Market Dynamics for Microbiology
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
9. US Medical and Diagnostic Laboratory Service Market, By Diagnostic Imaging Services
9.1. US Medical and Diagnostic Laboratory Service Market Overview, by Diagnostic Imaging Services
9.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Diagnostic Imaging Services, 2022 Vs 2030 (in %)
9.2. Radiology Services
9.2.1. US Medical and Diagnostic Laboratory Service Market, By Radiology Services, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Radiology Services
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Ultrasound Services
9.3.1. US Medical and Diagnostic Laboratory Service Market, By Ultrasound Services, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Ultrasound Services
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
10. US Medical and Diagnostic Laboratory Service Market, By Genetic Testing and Molecular Diagnostics
10.1. US Medical and Diagnostic Laboratory Service Market Overview, by Genetic Testing and Molecular Diagnostics
10.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Genetic Testing and Molecular Diagnostics, 2022 Vs 2030 (in %)
10.2. Genetic Testing
10.2.1. US Medical and Diagnostic Laboratory Service Market, By Genetic Testing, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Genetic Testing
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Molecular Diagnostics
10.3.1. US Medical and Diagnostic Laboratory Service Market, By Molecular Diagnostics, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Molecular Diagnostics
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
11. US Medical and Diagnostic Laboratory Service Market, By Blood Banking and Transfusion Services
11.1. US Medical and Diagnostic Laboratory Service Market Overview, by Blood Banking and Transfusion Services
11.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Blood Banking and Transfusion Services, 2022 Vs 2030 (in %)
11.2. Blood Typing and Crossmatching
11.2.1. US Medical and Diagnostic Laboratory Service Market, By Blood Typing and Crossmatching, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Blood Typing and Crossmatching
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Blood Donation Services
11.3.1. US Medical and Diagnostic Laboratory Service Market, By Blood Donation Services, 2017-2030 (US$ Mn)
11.3.2. Market Dynamics for Blood Donation Services
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
12. US Medical and Diagnostic Laboratory Service Market, By Point-of-Care Testing
12.1. US Medical and Diagnostic Laboratory Service Market Overview, by Point-of-Care Testing
12.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Point-of-Care Testing, 2022 Vs 2030 (in %)
12.2. Rapid Tests
12.2.1. US Medical and Diagnostic Laboratory Service Market, By Rapid Tests, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for Rapid Tests
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Home Testing Kits
12.3.1. US Medical and Diagnostic Laboratory Service Market, By Home Testing Kits, 2017-2030 (US$ Mn)
12.3.2. Market Dynamics for Home Testing Kits
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
13. US Medical and Diagnostic Laboratory Service Market, By Drug Testing Services
13.1. US Medical and Diagnostic Laboratory Service Market Overview, by Drug Testing Services
13.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Drug Testing Services, 2022 Vs 2030 (in %)
13.2. Workplace Drug Testing
13.2.1. US Medical and Diagnostic Laboratory Service Market, By Workplace Drug Testing, 2017-2030 (US$ Mn)
13.2.2. Market Dynamics for Workplace Drug Testing
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Forensic Drug Testing
13.3.1. US Medical and Diagnostic Laboratory Service Market, By Forensic Drug Testing, 2017-2030 (US$ Mn)
13.3.2. Market Dynamics for Forensic Drug Testing
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
14. US Medical and Diagnostic Laboratory Service Market, By Anatomic Pathology Services
14.1. US Medical and Diagnostic Laboratory Service Market Overview, by Anatomic Pathology Services
14.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Anatomic Pathology Services, 2022 Vs 2030 (in %)
14.2. Surgical Pathology
14.2.1. US Medical and Diagnostic Laboratory Service Market, By Surgical Pathology, 2017-2030 (US$ Mn)
14.2.2. Market Dynamics for Surgical Pathology
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
14.3. Cytopathology
14.3.1. US Medical and Diagnostic Laboratory Service Market, By Cytopathology, 2017-2030 (US$ Mn)
14.3.2. Market Dynamics for Cytopathology
14.3.2.1. Drivers
14.3.2.2. Restraints
14.3.2.3. Opportunities
14.3.2.4. Trends
15. US Medical and Diagnostic Laboratory Service Market, By Wellness and Preventive Health Testing
15.1. US Medical and Diagnostic Laboratory Service Market Overview, by Wellness and Preventive Health Testing
15.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Wellness and Preventive Health Testing, 2022 Vs 2030 (in %)
15.2. Health Screenings
15.2.1. US Medical and Diagnostic Laboratory Service Market, By Health Screenings, 2017-2030 (US$ Mn)
15.2.2. Market Dynamics for Health Screenings
15.2.2.1. Drivers
15.2.2.2. Restraints
15.2.2.3. Opportunities
15.2.2.4. Trends
15.3. Preventive Testing Packages
15.3.1. US Medical and Diagnostic Laboratory Service Market, By Preventive Testing Packages, 2017-2030 (US$ Mn)
15.3.2. Market Dynamics for Preventive Testing Packages
15.3.2.1. Drivers
15.3.2.2. Restraints
15.3.2.3. Opportunities
15.3.2.4. Trends
16. US Medical and Diagnostic Laboratory Service Market, By Home Healthcare Testing Services
16.1. US Medical and Diagnostic Laboratory Service Market Overview, by Home Healthcare Testing Services
16.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Home Healthcare Testing Services, 2022 Vs 2030 (in %)
16.2. Remote Monitoring
16.2.1. US Medical and Diagnostic Laboratory Service Market, By Remote Monitoring, 2017-2030 (US$ Mn)
16.2.2. Market Dynamics for Remote Monitoring
16.2.2.1. Drivers
16.2.2.2. Restraints
16.2.2.3. Opportunities
16.2.2.4. Trends
16.3. Home-Based Diagnostics
16.3.1. US Medical and Diagnostic Laboratory Service Market, By Home-Based Diagnostics, 2017-2030 (US$ Mn)
16.3.2. Market Dynamics for Home-Based Diagnostics
16.3.2.1. Drivers
16.3.2.2. Restraints
16.3.2.3. Opportunities
16.3.2.4. Trends
17. US Medical and Diagnostic Laboratory Service Market, By Cardiac Diagnostic Services
17.1. US Medical and Diagnostic Laboratory Service Market Overview, by Cardiac Diagnostic Services
17.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Cardiac Diagnostic Services, 2022 Vs 2030 (in %)
17.2. Cardiac Imaging
17.2.1. US Medical and Diagnostic Laboratory Service Market, By Cardiac Imaging, 2017-2030 (US$ Mn)
17.2.2. Market Dynamics for Cardiac Imaging
17.2.2.1. Drivers
17.2.2.2. Restraints
17.2.2.3. Opportunities
17.2.2.4. Trends
17.3. Electrocardiography (ECG or EKG)
17.3.1. US Medical and Diagnostic Laboratory Service Market, By Electrocardiography (ECG or EKG), 2017-2030 (US$ Mn)
17.3.2. Market Dynamics for Electrocardiography (ECG or EKG)
17.3.2.1. Drivers
17.3.2.2. Restraints
17.3.2.3. Opportunities
17.3.2.4. Trends
18. US Medical and Diagnostic Laboratory Service Market, By Infectious Disease Testing
18.1. US Medical and Diagnostic Laboratory Service Market Overview, by Infectious Disease Testing
18.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Infectious Disease Testing, 2022 Vs 2030 (in %)
18.2. Virology and Serology
18.2.1. US Medical and Diagnostic Laboratory Service Market, By Virology and Serology, 2017-2030 (US$ Mn)
18.2.2. Market Dynamics for Virology and Serology
18.2.2.1. Drivers
18.2.2.2. Restraints
18.2.2.3. Opportunities
18.2.2.4. Trends
18.3. Microbial Culture and Sensitivity
18.3.1. US Medical and Diagnostic Laboratory Service Market, By Microbial Culture and Sensitivity, 2017-2030 (US$ Mn)
18.3.2. Market Dynamics for Microbial Culture and Sensitivity
18.3.2.1. Drivers
18.3.2.2. Restraints
18.3.2.3. Opportunities
18.3.2.4. Trends
19. US Medical and Diagnostic Laboratory Service Market, By Women’s Health Testing
19.1. US Medical and Diagnostic Laboratory Service Market Overview, by Women’s Health Testing
19.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Women’s Health Testing, 2022 Vs 2030 (in %)
19.2. Prenatal Testing
19.2.1. US Medical and Diagnostic Laboratory Service Market, By Prenatal Testing, 2017-2030 (US$ Mn)
19.2.2. Market Dynamics for Prenatal Testing
19.2.2.1. Drivers
19.2.2.2. Restraints
19.2.2.3. Opportunities
19.2.2.4. Trends
19.3. Breast Cancer Screening
19.3.1. US Medical and Diagnostic Laboratory Service Market, By Breast Cancer Screening, 2017-2030 (US$ Mn)
19.3.2. Market Dynamics for Breast Cancer Screening
19.3.2.1. Drivers
19.3.2.2. Restraints
19.3.2.3. Opportunities
19.3.2.4. Trends
20. US Medical and Diagnostic Laboratory Service Market, By Urinalysis and Fluid Analysis
20.1. US Medical and Diagnostic Laboratory Service Market Overview, by Urinalysis and Fluid Analysis
20.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Urinalysis and Fluid Analysis, 2022 Vs 2030 (in %)
20.2. Urinalysis
20.2.1. US Medical and Diagnostic Laboratory Service Market, By Urinalysis, 2017-2030 (US$ Mn)
20.2.2. Market Dynamics for Urinalysis
20.2.2.1. Drivers
20.2.2.2. Restraints
20.2.2.3. Opportunities
20.2.2.4. Trends
20.3. Body Fluid Analysis
20.3.1. US Medical and Diagnostic Laboratory Service Market, By Body Fluid Analysis, 2017-2030 (US$ Mn)
20.3.2. Market Dynamics for Body Fluid Analysis
20.3.2.1. Drivers
20.3.2.2. Restraints
20.3.2.3. Opportunities
20.3.2.4. Trends
21. US Medical and Diagnostic Laboratory Service Market, By Telehealth and Remote Diagnostics
21.1. US Medical and Diagnostic Laboratory Service Market Overview, by Telehealth and Remote Diagnostics
21.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Telehealth and Remote Diagnostics, 2022 Vs 2030 (in %)
21.2. Telehealth Services
21.2.1. US Medical and Diagnostic Laboratory Service Market, By Telehealth Services, 2017-2030 (US$ Mn)
21.2.2. Market Dynamics for Telehealth Services
21.2.2.1. Drivers
21.2.2.2. Restraints
21.2.2.3. Opportunities
21.2.2.4. Trends
21.3. Remote Diagnostics
21.3.1. US Medical and Diagnostic Laboratory Service Market, By Remote Diagnostics, 2017-2030 (US$ Mn)
21.3.2. Market Dynamics for Remote Diagnostics
21.3.2.1. Drivers
21.3.2.2. Restraints
21.3.2.3. Opportunities
21.3.2.4. Trends
22. US Medical and Diagnostic Laboratory Service Market, By Health Information Management and Reporting
22.1. US Medical and Diagnostic Laboratory Service Market Overview, by Health Information Management and Reporting
22.1.1. US Medical and Diagnostic Laboratory Service Market Revenue Share, By Health Information Management and Reporting, 2022 Vs 2030 (in %)
22.2. Electronic Health Records (EHR)
22.2.1. US Medical and Diagnostic Laboratory Service Market, By Electronic Health Records (EHR), 2017-2030 (US$ Mn)
22.2.2. Market Dynamics for Electronic Health Records (EHR)
22.2.2.1. Drivers
22.2.2.2. Restraints
22.2.2.3. Opportunities
22.2.2.4. Trends
22.3. Health Information Exchange (HIE)
22.3.1. US Medical and Diagnostic Laboratory Service Market, By Health Information Exchange (HIE), 2017-2030 (US$ Mn)
22.3.2. Market Dynamics for Health Information Exchange (HIE)
22.3.2.1. Drivers
22.3.2.2. Restraints
22.3.2.3. Opportunities
22.3.2.4. Trends
23. Company Profiles
23.1. Mayo Clinic Laboratories
23.1.1. Company Overview
23.1.2. Products/Services Portfolio
23.1.3. Geographical Presence
23.1.4. SWOT Analysis
23.1.5. Financial Summary
23.1.5.1. Market Revenue and Net Profit (2019-2022)
23.1.5.2. Business Segment Revenue Analysis
23.1.5.3. Geographical Revenue Analysis
23.2. Genomic Health, Inc.
23.3. Myriad Genetics, Inc.
23.4. Others
24. Research Methodology
24.1. Research Methodology
24.2. Phase I – Secondary Research
24.3. Phase II – Data Modelling
24.3.1. Company Share Analysis Model
24.3.2. Revenue Based Modelling
24.4. Phase III – Primary Research
24.5. Research Limitations
24.5.1. Assumptions

List of Figures
FIG. 1 US Medical and Diagnostic Laboratory Service Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 US Medical and Diagnostic Laboratory Service Market Segmentation
FIG. 4 US Medical and Diagnostic Laboratory Service Market, by Clinical Laboratory Services, 2022 (US$ Mn)
FIG. 5 US Medical and Diagnostic Laboratory Service Market, by Diagnostic Imaging Services, 2022 (US$ Mn)
FIG. 6 US Medical and Diagnostic Laboratory Service Market, by Genetic Testing and Molecular Diagnostics, 2022 (US$ Mn)
FIG. 7 US Medical and Diagnostic Laboratory Service Market, by Blood Banking and Transfusion Services, 2022 (US$ Mn)
FIG. 8 US Medical and Diagnostic Laboratory Service Market, by Point-of-Care Testing, 2022 (US$ Mn)
FIG. 9 US Medical and Diagnostic Laboratory Service Market, by Drug Testing Services, 2022 (US$ Mn)
FIG. 10 US Medical and Diagnostic Laboratory Service Market, by Anatomic Pathology Services, 2022 (US$ Mn)
FIG. 11 US Medical and Diagnostic Laboratory Service Market, by Wellness and Preventive Health Testing, 2022 (US$ Mn)
FIG. 12 US Medical and Diagnostic Laboratory Service Market, by Home Healthcare Testing Services, 2022 (US$ Mn)
FIG. 13 US Medical and Diagnostic Laboratory Service Market, by Cardiac Diagnostic Services, 2022 (US$ Mn)
FIG. 14 US Medical and Diagnostic Laboratory Service Market, by Infectious Disease Testing, 2022 (US$ Mn)
FIG. 15 US Medical and Diagnostic Laboratory Service Market, by Women’s Health Testing, 2022 (US$ Mn)
FIG. 16 US Medical and Diagnostic Laboratory Service Market, by Urinalysis and Fluid Analysis, 2022 (US$ Mn)
FIG. 17 US Medical and Diagnostic Laboratory Service Market, by Telehealth and Remote Diagnostics, 2022 (US$ Mn)
FIG. 18 US Medical and Diagnostic Laboratory Service Market, by Health Information Management and Reporting, 2022 (US$ Mn)
FIG. 19 Attractive Investment Proposition, by Clinical Laboratory Services, 2022
FIG. 20 Attractive Investment Proposition, by Diagnostic Imaging Services, 2022
FIG. 21 Attractive Investment Proposition, by Genetic Testing and Molecular Diagnostics, 2022
FIG. 22 Attractive Investment Proposition, by Blood Banking and Transfusion Services, 2022
FIG. 23 Attractive Investment Proposition, by Point-of-Care Testing, 2022
FIG. 24 Attractive Investment Proposition, by Drug Testing Services, 2022
FIG. 25 Attractive Investment Proposition, by Anatomic Pathology Services, 2022
FIG. 26 Attractive Investment Proposition, by Wellness and Preventive Health Testing, 2022
FIG. 27 Attractive Investment Proposition, by Home Healthcare Testing Services, 2022
FIG. 28 Attractive Investment Proposition, by Cardiac Diagnostic Services, 2022
FIG. 29 Attractive Investment Proposition, by Infectious Disease Testing, 2022
FIG. 30 Attractive Investment Proposition, by Women’s Health Testing, 2022
FIG. 31 Attractive Investment Proposition, by Urinalysis and Fluid Analysis, 2022
FIG. 32 Attractive Investment Proposition, by Telehealth and Remote Diagnostics, 2022
FIG. 33 Attractive Investment Proposition, by Health Information Management and Reporting, 2022
FIG. 34 US Market Share Analysis of Key Medical and Diagnostic Laboratory Service Market Manufacturers, 2022
FIG. 35 US Market Positioning of Key Medical and Diagnostic Laboratory Service Market Manufacturers, 2022
FIG. 36 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Clinical Laboratory Services, 2022 & 2030 (Value %)
FIG. 37 US Medical and Diagnostic Laboratory Service Market, by Pathology Services, Value, 2017-2030 (US$ Mn)
FIG. 38 US Medical and Diagnostic Laboratory Service Market, by Clinical Chemistry, Value, 2017-2030 (US$ Mn)
FIG. 39 US Medical and Diagnostic Laboratory Service Market, by Hematology, Value, 2017-2030 (US$ Mn)
FIG. 40 US Medical and Diagnostic Laboratory Service Market, by Microbiology, Value, 2017-2030 (US$ Mn)
FIG. 41 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Diagnostic Imaging Services, 2022 & 2030 (Value %)
FIG. 42 US Medical and Diagnostic Laboratory Service Market, by Radiology Services, Value, 2017-2030 (US$ Mn)
FIG. 43 US Medical and Diagnostic Laboratory Service Market, by Ultrasound Services, Value, 2017-2030 (US$ Mn)
FIG. 44 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Genetic Testing and Molecular Diagnostics, 2022 & 2030 (Value %)
FIG. 45 US Medical and Diagnostic Laboratory Service Market, by Genetic Testing, Value, 2017-2030 (US$ Mn)
FIG. 46 US Medical and Diagnostic Laboratory Service Market, by Molecular Diagnostics, Value, 2017-2030 (US$ Mn)
FIG. 47 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Blood Banking and Transfusion Services, 2022 & 2030 (Value %)
FIG. 48 US Medical and Diagnostic Laboratory Service Market, by Blood Typing and Crossmatching, Value, 2017-2030 (US$ Mn)
FIG. 49 US Medical and Diagnostic Laboratory Service Market, by Blood Donation Services, Value, 2017-2030 (US$ Mn)
FIG. 50 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Point-of-Care Testing, 2022 & 2030 (Value %)
FIG. 51 US Medical and Diagnostic Laboratory Service Market, by Rapid Tests, Value, 2017-2030 (US$ Mn)
FIG. 52 US Medical and Diagnostic Laboratory Service Market, by Home Testing Kits, Value, 2017-2030 (US$ Mn)
FIG. 53 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Drug Testing Services, 2022 & 2030 (Value %)
FIG. 54 US Medical and Diagnostic Laboratory Service Market, by Workplace Drug Testing, Value, 2017-2030 (US$ Mn)
FIG. 55 US Medical and Diagnostic Laboratory Service Market, by Forensic Drug Testing, Value, 2017-2030 (US$ Mn)
FIG. 56 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Anatomic Pathology Services, 2022 & 2030 (Value %)
FIG. 57 US Medical and Diagnostic Laboratory Service Market, by Surgical Pathology, Value, 2017-2030 (US$ Mn)
FIG. 58 US Medical and Diagnostic Laboratory Service Market, by Cytopathology, Value, 2017-2030 (US$ Mn)
FIG. 59 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Wellness and Preventive Health Testing, 2022 & 2030 (Value %)
FIG. 60 US Medical and Diagnostic Laboratory Service Market, by Health Screenings, Value, 2017-2030 (US$ Mn)
FIG. 61 US Medical and Diagnostic Laboratory Service Market, by Preventive Testing Packages, Value, 2017-2030 (US$ Mn)
FIG. 62 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Home Healthcare Testing Services, 2022 & 2030 (Value %)
FIG. 63 US Medical and Diagnostic Laboratory Service Market, by Remote Monitoring, Value, 2017-2030 (US$ Mn)
FIG. 64 US Medical and Diagnostic Laboratory Service Market, by Home-Based Diagnostics, Value, 2017-2030 (US$ Mn)
FIG. 65 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Cardiac Diagnostic Services, 2022 & 2030 (Value %)
FIG. 66 US Medical and Diagnostic Laboratory Service Market, by Cardiac Imaging, Value, 2017-2030 (US$ Mn)
FIG. 67 US Medical and Diagnostic Laboratory Service Market, by Electrocardiography (ECG or EKG), Value, 2017-2030 (US$ Mn)
FIG. 68 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Infectious Disease Testing, 2022 & 2030 (Value %)
FIG. 69 US Medical and Diagnostic Laboratory Service Market, by Virology and Serology, Value, 2017-2030 (US$ Mn)
FIG. 70 US Medical and Diagnostic Laboratory Service Market, by Microbial Culture and Sensitivity, Value, 2017-2030 (US$ Mn)
FIG. 71 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Women’s Health Testing, 2022 & 2030 (Value %)
FIG. 72 US Medical and Diagnostic Laboratory Service Market, by Prenatal Testing, Value, 2017-2030 (US$ Mn)
FIG. 73 US Medical and Diagnostic Laboratory Service Market, by Breast Cancer Screening, Value, 2017-2030 (US$ Mn)
FIG. 74 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Urinalysis and Fluid Analysis, 2022 & 2030 (Value %)
FIG. 75 US Medical and Diagnostic Laboratory Service Market, by Urinalysis, Value, 2017-2030 (US$ Mn)
FIG. 76 US Medical and Diagnostic Laboratory Service Market, by Body Fluid Analysis, Value, 2017-2030 (US$ Mn)
FIG. 77 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Telehealth and Remote Diagnostics, 2022 & 2030 (Value %)
FIG. 78 US Medical and Diagnostic Laboratory Service Market, by Telehealth Services, Value, 2017-2030 (US$ Mn)
FIG. 79 US Medical and Diagnostic Laboratory Service Market, by Remote Diagnostics, Value, 2017-2030 (US$ Mn)
FIG. 80 US Medical and Diagnostic Laboratory Service Market Value Contribution, By Health Information Management and Reporting, 2022 & 2030 (Value %)
FIG. 81 US Medical and Diagnostic Laboratory Service Market, by Electronic Health Records (EHR), Value, 2017-2030 (US$ Mn)
FIG. 82 US Medical and Diagnostic Laboratory Service Market, by Health Information Exchange (HIE), Value, 2017-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: US Medical and Diagnostic Laboratory Service Market
TABLE 2 US Medical and Diagnostic Laboratory Service Market: Market Drivers Impact Analysis
TABLE 3 US Medical and Diagnostic Laboratory Service Market: Market Restraints Impact Analysis
TABLE 4 US Medical and Diagnostic Laboratory Service Market, by Competitive Benchmarking, 2022
TABLE 5 US Medical and Diagnostic Laboratory Service Market, by Geographical Presence Analysis, 2022
TABLE 6 US Medical and Diagnostic Laboratory Service Market, by Key Strategies Analysis, 2022
TABLE 7 US Medical and Diagnostic Laboratory Service Market, by Pathology Services, 2017-2022 (US$ Mn)
TABLE 8 US Medical and Diagnostic Laboratory Service Market, by Pathology Services, 2023-2030 (US$ Mn)
TABLE 9 US Medical and Diagnostic Laboratory Service Market, by Clinical Chemistry, 2017-2022 (US$ Mn)
TABLE 10 US Medical and Diagnostic Laboratory Service Market, by Clinical Chemistry, 2023-2030 (US$ Mn)
TABLE 11 US Medical and Diagnostic Laboratory Service Market, by Hematology, 2017-2022 (US$ Mn)
TABLE 12 US Medical and Diagnostic Laboratory Service Market, by Hematology, 2023-2030 (US$ Mn)
TABLE 13 US Medical and Diagnostic Laboratory Service Market, by Microbiology, 2017-2022 (US$ Mn)
TABLE 14 US Medical and Diagnostic Laboratory Service Market, by Microbiology, 2023-2030 (US$ Mn)
TABLE 15 US Medical and Diagnostic Laboratory Service Market, by Radiology Services, 2017-2022 (US$ Mn)
TABLE 16 US Medical and Diagnostic Laboratory Service Market, by Radiology Services, 2023-2030 (US$ Mn)
TABLE 17 US Medical and Diagnostic Laboratory Service Market, by Ultrasound Services, 2017-2022 (US$ Mn)
TABLE 18 US Medical and Diagnostic Laboratory Service Market, by Ultrasound Services, 2023-2030 (US$ Mn)
TABLE 19 US Medical and Diagnostic Laboratory Service Market, by Genetic Testing, 2017-2022 (US$ Mn)
TABLE 20 US Medical and Diagnostic Laboratory Service Market, by Genetic Testing, 2023-2030 (US$ Mn)
TABLE 21 US Medical and Diagnostic Laboratory Service Market, by Molecular Diagnostics, 2017-2022 (US$ Mn)
TABLE 22 US Medical and Diagnostic Laboratory Service Market, by Molecular Diagnostics, 2023-2030 (US$ Mn)
TABLE 23 US Medical and Diagnostic Laboratory Service Market, by Blood Typing and Crossmatching, 2017-2022 (US$ Mn)
TABLE 24 US Medical and Diagnostic Laboratory Service Market, by Blood Typing and Crossmatching, 2023-2030 (US$ Mn)
TABLE 25 US Medical and Diagnostic Laboratory Service Market, by Blood Donation Services, 2017-2022 (US$ Mn)
TABLE 26 US Medical and Diagnostic Laboratory Service Market, by Blood Donation Services, 2023-2030 (US$ Mn)
TABLE 27 US Medical and Diagnostic Laboratory Service Market, by Rapid Tests, 2017-2022 (US$ Mn)
TABLE 28 US Medical and Diagnostic Laboratory Service Market, by Rapid Tests, 2023-2030 (US$ Mn)
TABLE 29 US Medical and Diagnostic Laboratory Service Market, by Home Testing Kits, 2017-2022 (US$ Mn)
TABLE 30 US Medical and Diagnostic Laboratory Service Market, by Home Testing Kits, 2023-2030 (US$ Mn)
TABLE 31 US Medical and Diagnostic Laboratory Service Market, by Workplace Drug Testing, 2017-2022 (US$ Mn)
TABLE 32 US Medical and Diagnostic Laboratory Service Market, by Workplace Drug Testing, 2023-2030 (US$ Mn)
TABLE 33 US Medical and Diagnostic Laboratory Service Market, by Forensic Drug Testing, 2017-2022 (US$ Mn)
TABLE 34 US Medical and Diagnostic Laboratory Service Market, by Forensic Drug Testing, 2023-2030 (US$ Mn)
TABLE 35 US Medical and Diagnostic Laboratory Service Market, by Surgical Pathology, 2017-2022 (US$ Mn)
TABLE 36 US Medical and Diagnostic Laboratory Service Market, by Surgical Pathology, 2023-2030 (US$ Mn)
TABLE 37 US Medical and Diagnostic Laboratory Service Market, by Cytopathology, 2017-2022 (US$ Mn)
TABLE 38 US Medical and Diagnostic Laboratory Service Market, by Cytopathology, 2023-2030 (US$ Mn)
TABLE 39 US Medical and Diagnostic Laboratory Service Market, by Health Screenings, 2017-2022 (US$ Mn)
TABLE 40 US Medical and Diagnostic Laboratory Service Market, by Health Screenings, 2023-2030 (US$ Mn)
TABLE 41 US Medical and Diagnostic Laboratory Service Market, by Preventive Testing Packages, 2017-2022 (US$ Mn)
TABLE 42 US Medical and Diagnostic Laboratory Service Market, by Preventive Testing Packages, 2023-2030 (US$ Mn)
TABLE 43 US Medical and Diagnostic Laboratory Service Market, by Remote Monitoring, 2017-2022 (US$ Mn)
TABLE 44 US Medical and Diagnostic Laboratory Service Market, by Remote Monitoring, 2023-2030 (US$ Mn)
TABLE 45 US Medical and Diagnostic Laboratory Service Market, by Home-Based Diagnostics, 2017-2022 (US$ Mn)
TABLE 46 US Medical and Diagnostic Laboratory Service Market, by Home-Based Diagnostics, 2023-2030 (US$ Mn)
TABLE 47 US Medical and Diagnostic Laboratory Service Market, by Cardiac Imaging, 2017-2022 (US$ Mn)
TABLE 48 US Medical and Diagnostic Laboratory Service Market, by Cardiac Imaging, 2023-2030 (US$ Mn)
TABLE 49 US Medical and Diagnostic Laboratory Service Market, by Electrocardiography (ECG or EKG), 2017-2022 (US$ Mn)
TABLE 50 US Medical and Diagnostic Laboratory Service Market, by Electrocardiography (ECG or EKG), 2023-2030 (US$ Mn)
TABLE 51 US Medical and Diagnostic Laboratory Service Market, by Virology and Serology, 2017-2022 (US$ Mn)
TABLE 52 US Medical and Diagnostic Laboratory Service Market, by Virology and Serology, 2023-2030 (US$ Mn)
TABLE 53 US Medical and Diagnostic Laboratory Service Market, by Microbial Culture and Sensitivity, 2017-2022 (US$ Mn)
TABLE 54 US Medical and Diagnostic Laboratory Service Market, by Microbial Culture and Sensitivity, 2023-2030 (US$ Mn)
TABLE 55 US Medical and Diagnostic Laboratory Service Market, by Prenatal Testing, 2017-2022 (US$ Mn)
TABLE 56 US Medical and Diagnostic Laboratory Service Market, by Prenatal Testing, 2023-2030 (US$ Mn)
TABLE 57 US Medical and Diagnostic Laboratory Service Market, by Breast Cancer Screening, 2017-2022 (US$ Mn)
TABLE 58 US Medical and Diagnostic Laboratory Service Market, by Breast Cancer Screening, 2023-2030 (US$ Mn)
TABLE 59 US Medical and Diagnostic Laboratory Service Market, by Urinalysis, 2017-2022 (US$ Mn)
TABLE 60 US Medical and Diagnostic Laboratory Service Market, by Urinalysis, 2023-2030 (US$ Mn)
TABLE 61 US Medical and Diagnostic Laboratory Service Market, by Body Fluid Analysis, 2017-2022 (US$ Mn)
TABLE 62 US Medical and Diagnostic Laboratory Service Market, by Body Fluid Analysis, 2023-2030 (US$ Mn)
TABLE 63 US Medical and Diagnostic Laboratory Service Market, by Telehealth Services, 2017-2022 (US$ Mn)
TABLE 64 US Medical and Diagnostic Laboratory Service Market, by Telehealth Services, 2023-2030 (US$ Mn)
TABLE 65 US Medical and Diagnostic Laboratory Service Market, by Remote Diagnostics, 2017-2022 (US$ Mn)
TABLE 66 US Medical and Diagnostic Laboratory Service Market, by Remote Diagnostics, 2023-2030 (US$ Mn)
TABLE 67 US Medical and Diagnostic Laboratory Service Market, by Electronic Health Records (EHR), 2017-2022 (US$ Mn)
TABLE 68 US Medical and Diagnostic Laboratory Service Market, by Electronic Health Records (EHR), 2023-2030 (US$ Mn)
TABLE 69 US Medical and Diagnostic Laboratory Service Market, by Health Information Exchange (HIE), 2017-2022 (US$ Mn)
TABLE 70 US Medical and Diagnostic Laboratory Service Market, by Health Information Exchange (HIE), 2023-2030 (US$ Mn)
TABLE 71 US Medical and Diagnostic Laboratory Service Market, by Clinical Laboratory Services, 2017-2022 (US$ Mn)
TABLE 72 US Medical and Diagnostic Laboratory Service Market, by Clinical Laboratory Services, 2023-2030 (US$ Mn)
TABLE 73 US Medical and Diagnostic Laboratory Service Market, by Diagnostic Imaging Services, 2017-2022 (US$ Mn)
TABLE 74 US Medical and Diagnostic Laboratory Service Market, by Diagnostic Imaging Services, 2023-2030 (US$ Mn)
TABLE 75 US Medical and Diagnostic Laboratory Service Market, by Genetic Testing and Molecular Diagnostics, 2017-2022 (US$ Mn)
TABLE 76 US Medical and Diagnostic Laboratory Service Market, by Genetic Testing and Molecular Diagnostics, 2023-2030 (US$ Mn)
TABLE 77 US Medical and Diagnostic Laboratory Service Market, by Blood Banking and Transfusion Services, 2017-2022 (US$ Mn)
TABLE 78 US Medical and Diagnostic Laboratory Service Market, by Blood Banking and Transfusion Services, 2023-2030 (US$ Mn)
TABLE 79 US Medical and Diagnostic Laboratory Service Market, by Point-of-Care Testing, 2017-2022 (US$ Mn)
TABLE 80 US Medical and Diagnostic Laboratory Service Market, by Point-of-Care Testing, 2023-2030 (US$ Mn)
TABLE 81 US Medical and Diagnostic Laboratory Service Market, by Drug Testing Services, 2017-2022 (US$ Mn)
TABLE 82 US Medical and Diagnostic Laboratory Service Market, by Drug Testing Services, 2023-2030 (US$ Mn)
TABLE 83 US Medical and Diagnostic Laboratory Service Market, by Anatomic Pathology Services, 2017-2022 (US$ Mn)
TABLE 84 US Medical and Diagnostic Laboratory Service Market, by Anatomic Pathology Services, 2023-2030 (US$ Mn)
TABLE 85 US Medical and Diagnostic Laboratory Service Market, by Wellness and Preventive Health Testing, 2017-2022 (US$ Mn)
TABLE 86 US Medical and Diagnostic Laboratory Service Market, by Wellness and Preventive Health Testing, 2023-2030 (US$ Mn)
TABLE 87 US Medical and Diagnostic Laboratory Service Market, by Home Healthcare Testing Services, 2017-2022 (US$ Mn)
TABLE 88 US Medical and Diagnostic Laboratory Service Market, by Home Healthcare Testing Services, 2023-2030 (US$ Mn)
TABLE 89 US Medical and Diagnostic Laboratory Service Market, by Cardiac Diagnostic Services, 2017-2022 (US$ Mn)
TABLE 90 US Medical and Diagnostic Laboratory Service Market, by Cardiac Diagnostic Services, 2023-2030 (US$ Mn)
TABLE 91 US Medical and Diagnostic Laboratory Service Market, by Infectious Disease Testing, 2017-2022 (US$ Mn)
TABLE 92 US Medical and Diagnostic Laboratory Service Market, by Infectious Disease Testing, 2023-2030 (US$ Mn)
TABLE 93 US Medical and Diagnostic Laboratory Service Market, by Women’s Health Testing, 2017-2022 (US$ Mn)
TABLE 94 US Medical and Diagnostic Laboratory Service Market, by Women’s Health Testing, 2023-2030 (US$ Mn)
TABLE 95 US Medical and Diagnostic Laboratory Service Market, by Urinalysis and Fluid Analysis, 2017-2022 (US$ Mn)
TABLE 96 US Medical and Diagnostic Laboratory Service Market, by Urinalysis and Fluid Analysis, 2023-2030 (US$ Mn)
TABLE 97 US Medical and Diagnostic Laboratory Service Market, by Telehealth and Remote Diagnostics, 2017-2022 (US$ Mn)
TABLE 98 US Medical and Diagnostic Laboratory Service Market, by Telehealth and Remote Diagnostics, 2023-2030 (US$ Mn)
TABLE 99 US Medical and Diagnostic Laboratory Service Market, by Health Information Management and Reporting, 2017-2022 (US$ Mn)
TABLE 100 US Medical and Diagnostic Laboratory Service Market, by Health Information Management and Reporting, 2023-2030 (US$ Mn)

How big is the US medical and diagnostic laboratory services market right now?

In 2022, the US medical and diagnostic laboratory service market was estimated to be worth USD 72514.8 million.

What is the US medical and diagnostic laboratory service market’s anticipated growth rate from 2023 to 2030?

The US medical and diagnostic laboratory services market is anticipated to increase at a CAGR of 9.50% from 2023 to 2030, reaching USD 149878.59 million in 2030.

Which market category is in the lead for clinical laboratory services?

Pathology services are the most popular clinical laboratory services category.

Which segment is leading the market in terms of diagnostic imaging services?

The notable segment is radiology services by diagnostic imaging services.

Which cardiac diagnostic services segment is estimated to have the highest CAGR throughout the forecast period?

The cardiac imaging category is anticipated to exhibit the highest CAGR during the projection period.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –